Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA7 | P43166 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 4/20 | 0.55 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 5/20 | 0.48 |
| ▸ | AGXT | P21549 | 3/20 | 0.48 |
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7640115 | 0.86 | AGXT (0.56) | MAOBTAAR1TDP1AGXT | |
| SCHEMBL321542 | 0.80 | TAAR1 (0.60) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3246110 | 0.79 | WDR5 (0.54) | CA1CA2CA9TDP1ALDH1A1 | |
| Bromide SCHEMBL9464051 | 0.78 | TAAR1 (0.58) | CA12CA1CA2CA7CA9 | |
| Hydrochloric Acid SCHEMBL1623684 | 0.78 | TAAR1 (0.58) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1010741 | 0.78 | TAAR1 (0.54) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1343630 | 0.78 | CA12 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10637391 | 0.78 | CA1 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL17667163 | 0.77 | TDP1 (0.50) | MAOBTAAR1TDP1MAPK1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL4385466 | 0.77 | MAOB (0.53) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | claimed |
| EP-3381915-B1 | LACTAM COMPOUND DERIVATIVE AND APPLICATION THEREOF | NHWA PHARMA CORP (CN) | 2023-01-18 | — | — | EP | disclosed |
| US-20200399540-A1 | BROMINATED FLAME-RETARDANT TETRAZINES | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2020-12-24 | — | — | US | disclosed |
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | disclosed |
| US-20180327397-A1 | LACTAM COMPOUND DERIVATIVE AND APPLICATION THEREOF | NHWA PHARMA. CORPORATION (CN) | 2018-11-15 | — | — | US | disclosed |
| EP-3381915-A1 | LACTAM COMPOUND DERIVATIVE AND APPLICATION THEREOF | NHWA Pharma Corporation (CN) | 2018-10-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180327397-A1 | LACTAM COMPOUND DERIVATIVE AND APPLICATION THEREOF | BACE1, QPCT, PSENEN | CA12 2647/4885CA1 3150/4885CA2 4835/4885 |
| US-20200399540-A1 | BROMINATED FLAME-RETARDANT TETRAZINES | PBRM1, NBAS, TIPRL | CA12 1900/4885CA1 1303/4885CA2 3970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.